CPAI / Northern Lights Fund Trust III - Counterpoint Quantitative Equity ETF - Depositi SEC, Relazione annuale, dichiarazione di delega

CPAI / Champion Pain Care Corporation / Tca Global Credit Master Fund Lp. - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, Par Value $0.0001 (Title of Class of Securities) 158571109 (CUSIP Number) TCA Global Credit Master Fund, LP P.O. Box 1043, 69 Dr. Roy’s Drive, George Town Grand Cayman KY1-1102, Cayman Islands (345) 914-4857 (Na

Champion Pain Care NT 10-K/A

Champion Pain Care NT 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Champion Pain Care NT 10-K

Form 12b-25 - Canwealth (2014 Form 10-K) (01150257).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING CUSIPNUMBER (Check one): x Form 10-K o Form 20-F o Form 11 ?K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 2016 o Transition Report on Form 10-K o Transition Report on Form 20-F o

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Champion Pain Care 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

February 8, 2017 NOTICE OF DEFAULT

EX-99.2 4 exhibit99201546559xb2f1a.htm NOTICE OF DEFAULT DATED FEBRUARY 8, 2017 FROM TCA GLOBAL CREDIT MASTER FUND, L.P. February 8, 2017 NOTICE OF DEFAULT Champion Pain Care Garland A Brown Jr. 48 Wall Street New York, NY 10005 [email protected] Re: SENIOR SECURED CREDIT FACILITY AGREEMENT dated as of MARCH 31, 2016 but made effective as of DECEMBER 1, 2016 (the “Agreement”) by and bet

Thank you. Very truly yours,

Converted by EDGARwiz 19950 West Country Club Drive, #101 Aventura, FL 33180 Tel: (786) 323-1650 Fax: (786) 323-1651 March 7, 2017 Via E-Mail (david@dkpalaw.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Champion Pain Care Corporation 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Champion Pain Care DEF 14C

Converted by EDGARwiz SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ X ] Definitive Information Statement CHAMPION PAIN CARE CORPORATION (Name of Registrant as Specified in its Charter) Payment of Filing Fee (Check the appropriate box): [ X ] No fee required [ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.

Champion Pain Care Corporation Closes a Credit Facility and Acquires Two Pain Management Clinics

Converted by EDGARwiz Champion Pain Care Corporation Closes a Credit Facility and Acquires Two Pain Management Clinics New York, December 5, 2016 - On December 1, 2016, Champion Pain Care Corporation (OTCQB:CPAI) closed a Senior Secured Credit Facility (the ?Credit Facility?) with TCA Global Credit Master Fund, LP (?TCA?) for a maximum $13 million senior secured line of credit, of which the initial line of credit is $6,500,000 is made available to the Company to fund acquisitions of pain management clinics and provide working capital.

CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES A PREFERRED STOCK CHAMPION PAIN CARE CORPORATION

EX-10.20 2 f1020.htm EXHIBIT 10.20 EXHIBIT 10.20 CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES A PREFERRED STOCK of CHAMPION PAIN CARE CORPORATION Champion Pain Care Corporation, a Delaware corporation (the “Corporation”), hereby certifies that, pursuant to the authority conferred upon the Board of Directors of the Corporation (th

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES B SUPER VOTING PREFERRED STOCK CHAMPION PAIN CARE CORPORATION

Certificate of Designations - Series A Preferred Tarsier Ltd (01295782-2).DOC EXHIBIT 10.21 CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES B SUPER VOTING PREFERRED STOCK of CHAMPION PAIN CARE CORPORATION Champion Pain Care Corporation, a Delaware corporation (the ?Corporation?), hereby certifies that, pursuant to the authority conf

CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CHAMPION PAIN CARE CORPORATION

Converted by EDGARwiz EXHIBIT I CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CHAMPION PAIN CARE CORPORATION First: That the Board of Directors of Champion Pain Care Corporation, a Delaware corporation (the ?Corporation?) by Unanimous Written Consent dated as of November 10, 2016, adopted resolutions setting forth a proposed amendment to the Certificate of Incorporation of the Corporation, declaring said amendment to be advisable and calling for the submission of such amendment to the stockholders of the Corporation for consideration thereof.

Champion Pain Care PRE 14C

Converted by EDGARwiz SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement CHAMPION PAIN CARE CORPORATION (Name of Registrant as Specified in its Charter) Payment of Filing Fee (Check the appropriate box): [ X ] No fee required [ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.

SCHEDULE A CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES A PREFERRED STOCK CHAMPION PAIN CARE CORPORATION

Certificate of Designations - Series A Preferred Tarsier Ltd (01295782-2).DOC SCHEDULE A CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES A PREFERRED STOCK of CHAMPION PAIN CARE CORPORATION Champion Pain Care Corporation, a Delaware corporation (the ?Corporation?), hereby certifies that, pursuant to the authority conferred upon the B

SCHEDULE B CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES B SUPER VOTING PREFERRED STOCK CHAMPION PAIN CARE CORPORATION

Certificate of Designations - Series A Preferred Tarsier Ltd (01295782-2).DOC SCHEDULE B CERTIFICATE OF DESIGNATION of the PREFERENCES, RIGHTS, LIMITATIONS, QUALIFICATIONS AND RESTRICTIONS of the SERIES B SUPER VOTING PREFERRED STOCK of CHAMPION PAIN CARE CORPORATION Champion Pain Care Corporation, a Delaware corporation (the ?Corporation?), hereby certifies that, pursuant to the authority conferr

Champion Pain Care FORM 10-Q (Quarterly Report)

Converted by EDGARwiz U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2016 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 Champi

Champion Pain Care NT-10-Q

NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [ ] Form 10-K [X] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: September 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Repo

Champion Pain Care FORM 10-Q (Quarterly Report)

Converted by EDGARwiz U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2016 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 Champion Pa

Champion Pain Care FORM 10-Q (Quarterly Report)

Converted by EDGARwiz U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2016 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 Champion Pa

Champion Pain Care NT 10-Q

NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [ ] Form 10-K [X] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: June 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on

Champion Pain Care NT 10-Q

NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [ ] Form 10-K [X] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: June 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on

Champion Pain Care FORM 10-Q (Quarterly Report)

Converted by EDGARwiz U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2016 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 Champion P

Champion Pain Care NT 10-Q

CYTTA CORP. (Form: NT 10-Q, Received: 05/14/2013 13:03:27) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [ ] Form 10-K [X] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: March 31, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Tra

CPAI / Champion Pain Care Corporation / Schiller Emil - SC 13D/A Activist Investment

SC 13D/A 1 emilsc13da105may16.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 158571109 (CUSIP Number) Emil Schiller 635 Fourth Line (Unit 1) Oakville, ON, Canada L6L

CPAI / Champion Pain Care Corporation / Conner Mark - SC 13D/A Activist Investment

Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 158571109 (CUSIP Number) Mark H. Conner 2207 North 11th Avenue Phoenix, AZ 85007 1. 602.391.3128 (Name, Address and Te

Champion Pain Care FORM 10-K (Annual Report)

10-K 1 f10k2016finaldraft41116.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 Commission file number: 333-162084 Champion Pain Care Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 27-06253

CPAI / Champion Pain Care Corporation / Gold Jason - SC 13G/A Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 158571109 (CUSIP Number) Jason Gold 1137 Quick Street Newmarket, Ontario, Canada L3X 0A6 (416) 917-0067 (Name, Address

CPAI / Champion Pain Care Corporation / Gold Allan - SC 13G/A Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 158571109 (CUSIP Number) Allan Gold 1798 - 131 Torresdale Avenue Toronto, Ontario, Canada M2R 3T1 (416) 414-3404 (Name

Current Report

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Champion Pain Care NT 10-K

CYTTA CORP. (Form: NT 10-Q, Received: 05/14/2013 13:03:27) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [X ] Form 10-K [] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: December 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ]

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q

10-Q 1 f15q3cpai10qfinal11nov15.htm FORM 10-Q U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission Fi

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 Champion Pain Care Corporation (N

Champion Pain Care FORM NT 10-Q

CYTTA CORP. (Form: NT 10-Q, Received: 05/14/2013 13:03:27) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [ ] Form 10-K [X] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: June 30, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Tran

CPAI / Champion Pain Care Corporation / Conner Mark - SCHEDULE 13D Activist Investment

SC 13D 1 mhcsc13d.htm SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 158571109 (CUSIP Number) Mark H. Conner 6263 N. Scottsdale Road, Suite 340 Scottsdale, AZ 85250 1.

CPAI / Champion Pain Care Corporation / CGPM, LLC - SCHEDULE 13G/A Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 158571109 (CUSIP Number) CGPM, LLC 200 Red Tail Court Ashton, MD 20905 1-301-442-4230 (Name, Address and Telephone Num

CPAI / Champion Pain Care Corporation / Brown Garland Jr. - SC 13D Activist Investment

Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 158571109 (CUSIP Number) Garland A. Brown, Jr. 6263 N. Scottsdale Road, Suite 340 Scottsdale, AZ 85250 1.480.327.6652 (Na

CPAI / Champion Pain Care Corporation / Champion Care Corp. - SC 13D/A Activist Investment

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2) CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Terrance Owen Champion Care Corp. 635 Fourth Line (Unit 1) Oakville, Ontario L6L 5BO, Canada

EXECUTIVE EMPLOYMENT AGREEMENT

Converted by EDGARwiz EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement, including the Confidentiality & Non-Solicitation Agreement attached hereto as Exhibit ?A? and incorporated herein by reference (collectively, the ?Agreement?), is made and entered into as of this 12th day of June, 2015 (?Effective Date?), by and between Champion Pain Care Corporation, a Delaware corporation (the ?Company?) and Garland A.

AMENDMENT TO SERVICES AGREEMENT June 12, 2015

EX-10.13 6 ex1013amendmenttoservicesagr.htm AMENDMENT TO THE SERVICES AGREEMENT DATED JUNE 12, 2015 BETWEEN THE COMPANY AND CHAMPION CARE CORP. AMENDMENT TO SERVICES AGREEMENT June 12, 2015 BETWEEN: Champion Care Corp. 635 Fourth Line, Unit 1 Oakville, ON, Canada L6L 5B0 (Referred to as “Champion Toronto”) AND Champion Pain Care Corporation (formerly OICco Acquisition I, Inc.) 48 Wall Street, 10th

Financial Statements and Exhibits

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

AMENDMENT TO SERVICES AGREEMENT April 1, 2015

EX-10.12 5 ex1012amendmenttoservicesagr.htm AMENDMENT TO THE SERVICES AGREEMENT DATED APRIL 1, 2015 BETWEEN THE COMPANY AND CHAMPION CARE CORP. AMENDMENT TO SERVICES AGREEMENT April 1, 2015 BETWEEN: Champion Care Corp. 635 Fourth Line, Unit 1 Oakville, ON, Canada L6L 5B0 (Referred to as “Champion Toronto”) AND Champion Pain Care Corporation (formerly OICco Acquisition I, Inc.) 48 Wall Street, 10th

EXECUTIVE EMPLOYMENT AGREEMENT

Converted by EDGARwiz EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement, including the Confidentiality & Non-Solicitation Agreement attached hereto as Exhibit ?A? and incorporated herein by reference (collectively, the ?Agreement?), is made and entered into as of this 12th day of June, 2015 (?Effective Date?), by and between Champion Pain Care Corporation, a Delaware corporation (the ?Company?) and Mark H.

EXECUTIVE SERVICES AGREEMENT

Converted by EDGARwiz EXECUTIVE SERVICES AGREEMENT This Executive Services Agreement, including the Confidentiality & Non-Solicitation Agreement attached hereto as Exhibit ?A? and incorporated herein by reference (collectively, the ?Agreement?), is made and entered into this 12th day of June, 2015 (?Effective Date?), by and between Champion Pain Care Corporation, a Delaware corporation (the ?Company?) and Jack Fishman (?Executive? or ?you?) (collectively, the ?parties?).

STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CHAMPION PAIN CARE CORPORATION

EX-3.4 2 exhibit34.htm CERTIFICATE OF AMENDMENT FILED JUNE 1, 2015 STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CHAMPION PAIN CARE CORPORATION First: That the Board of Directors of Champion Pain Care Corporation (the “Corporation”) by Unanimous Written Consent dated as of April 22, 2015, adopted resolutions setting forth a proposed amendment to the Certificate of I

Champion Pain Care DEF 14C

Converted by EDGARwiz SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ X ] Definitive Information Statement CHAMPION PAIN CARE CORPORATION (Name of Registrant as Specified in its Charter) Payment of Filing Fee (Check the appropriate box): [ X ] No fee required [ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.

Financial Statements and Exhibits

8-K 1 f8kshareincrease05jun15.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2015 333-162084 Commission File Number Champion Pain Care Corporation (Exact name of registrant as specified in its charter) Delawar

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q

10-Q 1 f15q110qfinal19may15.htm FORM 10-Q U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 3

CPAI / Champion Pain Care Corporation / CGPM, LLC - SC 13G Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 158571109 (CUSIP Number) CGPM, LLC 200 Red Tail Court Ashton, MD 20905 1-301-442-4230 (Name, Address and Telephone Number

Champion Pain Care NT 10-Q

CYTTA CORP. (Form: NT 10-Q, Received: 05/14/2013 13:03:27) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [ ] Form 10-K [X] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: March 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Tra

Financial Statements and Exhibits

8-K 1 f8kseccgpmshares06may15s.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2015 333-162084 Commission File Number Champion Pain Care Corporation (Exact name of registrant as specified in its charter) Dela

CHAMPION PAIN CARE CORPORATION. CONSULTING AGREEMENT

Recent Price: $0 CHAMPION PAIN CARE CORPORATION. CONSULTING AGREEMENT Agreement made as of the 1st day of May, 2015 by and between Champion Pain Care Corporation, a Delaware corporation with an address for doing business at 48 Wall Street, New York, NY 10005 (the ?Company?) and CGPM, LLC, a Maryland limited liability company, with an office for doing business at 200 Red Tail Court, Ashton, MD 2090

Champion Pain Care PRE 14C

Converted by EDGARwiz SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement CHAMPION PAIN CARE CORPORATION (Name of Registrant as Specified in its Charter) Payment of Filing Fee (Check the appropriate box): [ X ] No fee required [ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission file number: 333-16208

10-K 1 f10k28apr15final.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Commission file number: 333-162084 Champion Pain Care Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 27-0625383 (Sta

Champion Pain Care NT 10-K

Champion NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [X ] Form 10-K [] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: December 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transit

CPAI / Champion Pain Care Corporation / Champion Pain Care Corp - SC 13D/A Activist Investment

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Terrance Owen Champion Care Corp. 635 Fourth Line (Unit 1) Oakville, Ontario L6L 5BO, Canada

CPAI / Champion Pain Care Corporation / Champion Pain Care Corp - SC 13D Activist Investment

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Emil Schiller Champion Care Corp. 635 Fourth Line (Unit 1) Oakville, Ontario L6L 5BO, Canada (604) 862-3439 Copy

CPAI / Champion Pain Care Corporation / Champion Pain Care Corp - SC 13G Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Sheena Sim 635 Fourth Line (Unit 1) Oakville, Ontario, Canada L6L 5BO (905) 257-8191 (Name, Add

CPAI / Champion Pain Care Corporation / Champion Pain Care Corp - SC 13G Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Patricia Genereaux 635 Fourth Line (Unit 1) Oakville, Ontario, Canada L6L 5BO (604) 763-6537 (N

CPAI / Champion Pain Care Corporation / Champion Pain Care Corp - SC 13D Activist Investment

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Jack Fishman Champion Care Corp. 635 Fourth Line (Unit 1) Oakville, Ontario L6L 5BO, Canada (604) 862-3439 Copy

CPAI / Champion Pain Care Corporation / Champion Pain Care Corp - SC 13G Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Allan Gold 1798 - 131 Torresdale Avenue Toronto, Ontario, Canada M2R 3T1 (416) 414-3404 (Name,

CPAI / Champion Pain Care Corporation / Champion Pain Care Corp - SC 13D Activist Investment

UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Terrance Owen Champion Care Corp. 635 Fourth Line (Unit 1) Oakville, Ontario L6L 5BO, Canada (604) 862-3439 Copy

CPAI / Champion Pain Care Corporation / Champion Pain Care Corp - SC 13G Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CHAMPION PAIN CARE CORPORATION (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Jason Gold 2901 – 199 Bay Street Toronto, Ontario, Canada M5L 1G1 (416) 917-0067 (Name, Address

Services Agreement

July 1, 2014 Services Agreement BETWEEN: Champion Care Corp. Champion Toronto 635 Fourth Line, Unit 1 Oakville, ON, Canada L6L 5B0 AND OICCO ACQUISITION I, INC. 48 Wall Street, 10th Floor New York, NY 10005 WITNESSETH: WHEREAS, on February 1, 2013, Champion Pain Care Corp., a Nevada corporation (“Champion Nevada”), was granted a license in the United States (“the License”) to the Champion Pain Car

LICENSE TRANSFER AGREEMENT

LICENSE TRANSFER AGREEMENT This License Transfer Agreement (“Agreement”), effective as of the 23rd day of October, 2013, is between Champion Pain Care Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

10-Q 1 f14q318nov14.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission F

CPAI / Champion Pain Care Corporation NT 10-Q - - FORM NT 10-Q

Champion Pain Care NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Financial Statements and Exhibits

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

EXHIBIT 3.4 CERTIFICATE OF AMENDMENT

Converted by EDGARwiz EXHIBIT 3.4 CERTIFICATE OF AMENDMENT

CPAI / Champion Pain Care Corporation DEF 14C - - DEFINITIVE INFORMATION STATEMENT

Converted by EDGARwiz SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement OICCO ACQUISITION I, INC.

CPAI / Champion Pain Care Corporation PRE 14C - - PRE 14-C

Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q

10-Q 1 f14q2oicco10q30jun14.htm FORM 10-Q U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No

CPAI / Champion Pain Care Corporation NT 10-Q - - NT 10-Q

Oicco Acquisition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [ ] Form 10-K [X] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: June 30, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION

10-Q 1 oicco10q14q1.htm FORM 10-Q U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-16208

- NT 10-Q

NT Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-162084 (Check One): [ ] Form 10-K [X] Form 10-Q [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: March 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report

CPAI / Champion Pain Care Corporation / Champion Care Corp. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 OICCO ACQUISITION I, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 6777V 10 1 (CUSIP Number) Terrance Owen Champion Care Corp. 635 Fourth Line (Unit 1) Oakville, Ontario L6L 5BO, Canada (604) 862-3439 Copy to: Gerald A. Adle

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Commission file number: 333-16208

10-K 1 oic-10k123113.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Commission file number: 333-162084 OICco Acquisition I, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 27-0625383 (State o

- NOTICE OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR o Form N-CSR For the Period Ended: December 31, 2013 o Transition Report on Form 10-K o Transition Report on Form 10-Q o Transition Report on Form 20-F o Transition Report on Form N-SAR o Transition Report on Form 11-K For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2014 OICco Acquisition I, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 333-162084 27-0625383 (State or other Jurisdiction of Incorporation) (Commi

OICco Acquisition I, Inc. 8-K

OICco Acquisition I, Inc. 8-K Exhibit 99.1 Champion Pain Care Corp. OICco Acquisition I, Inc. (to be renamed Champion Pain Care Corp.) will deliver a proprietary treatment protocol for chronic pain (the “Protocol”) through pain management practices it acquires in the United States. Summary • There is a large and growing market for pain management • Current services are highly fragmented with appro

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q

10-Q 1 oic-10q093013.htm QUARTERLY REPORT U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File N

License Agreement by and between Champion Pain Care Corp. (Toronto) and Champion Pain Care Corp. (Nevada) dated February 1, 2013

OICco Acquisition I, Inc. 8-K Exhibit 10.5 LICENSE AGREEMENT LICENSE AGREEMENT dated as of February 1, 2013, between Champion Care Corp. (“Licensor”), a corporation incorporated under the laws of Ontario, Canada having its principal place of business at 307-208 Evans Avenue, Toronto, Ontario, Canada M8Z 1J7 and Champion Pain Care Corp. (“Licensee”), a Nevada corporation having its principal place

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2013 OICco Acquisition I, Inc. (Exact name of registrant as specified in its charter) Delaware 333-162084 27-0625383 (State or other Jurisdiction of Incorporation) (Commis

Services Agreement by and between Champion Pain Care Corp. (Toronto) and Champion Pain Care Corp. (Nevada) dated February 1, 2013

EX-10.6 4 ex10-6.htm SERVICES AGREEMENT OICco Acquisition I, Inc. 8-K Exhibit 10.6 February 1, 2013 Services Agreement BETWEEN: Champion Care Corp. (“CCC”) 307 - 208 Evans Avenue Toronto, Ontario, Canada M8Z 1J7 and Champion Pain Care Corp. (“CPCC”) 123 West Nye Lane, Suite 129 Carson City, Nevada 89706. Dear Dr Owen, Our combined efforts will solidify a strong and viable market position for Champ

Share Exchange Agreement and Plan of Reorganization by and between OICCo and Champion Pain Care Corp., dated May 25, 2013

EX-10.4 2 ex10-4.htm SHARES EXCHANGE AGREEMENT OICco Acquisition I, Inc. 8-K Exhibit 10-4 SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION This SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION (this “Agreement”) is entered into as of this 29th day of May, 2013 by and among, OICco Acquisition I, Inc., a Delaware corporation (“OICco”), Champion Pain Care Corp., a Nevada corporation (“CHAMPION”

OICCO ACQUISITION I, INC.

OICco Acquisition I, Inc. 8-K Exhibit 99.2 OICCO ACQUISITION I, INC. (A Development Stage Company) Unaudited Combined Pro Forma Balance Sheet June 30, 2013 OICCO Acquisition I, Inc. CHAMPION PAIN CARE CORP. Pro Forma Adjustmetns Adjusted Pro Forma Totals ASSETS Current assets Cash $ 1,505 $ 100 $ — $ 1,605 Total current assets 1,505 100 1,605 Total assets $ 1,505 $ 100 $ — $ 1,605 LIABILITIES AND

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

OICco Acquisition I, Inc. 8-K Exhibit 99.1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors Champion Pain Care Corp. New York, NY (A Development Stage Company) We have audited the accompanying balance sheet of Champion Pain Care Corp. (a development stage company) (the “Company”) as of June 30, 2013 and the related statements of expenses, changes in stockholders’ defi

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A1 (Amendment No. 1)

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A1 (Amendment No. 1) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 OICco Acqui

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q /A2 (Amendment No. 2) x . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 o. TRANSITION RE

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q /A2 (Amendment No. 2) x . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 o. TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 OICco Ac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A2 (Amendment No. 2) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission f

10-K/A 1 oic-10ka123112.htm AMENDED ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A2 (Amendment No. 2) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission file number: 333-162084 OICco Acquisition I, Inc. (Exact Name of Registrant as Specified in its Chart

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A2 (Amendment No.2) x . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2012 o . TRANSITIO

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A2 (Amendment No.2) x . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2012 o . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 OICc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A3 (Amendment No. 3) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Commission f

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A3 (Amendment No. 3) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Commission file number: 333-162084 OICco Acquisition I, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 27-0625383 (State or Other Jurisdicti

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A2 (Amendment No. 2) x . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 o. TRANSITION RE

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A2 (Amendment No. 2) x . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 o. TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 OICco Ac

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A1 (Amendment No. 1)

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A1 (Amendment No. 1) S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2012 £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 OICco Acquis

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 . TRANSITION REPO

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 OICco Acqu

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q /A (Amendment No. 1) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 . TRANSITION REPO

10-Q/A 1 f10qa06301310qz.htm FORM 10-Q/A AMENDED QUARTERLY REPORT U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q /A (Amendment No. 1) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the t

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2012 . TRANSITION REPORT PURSUANT TO S

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2012 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-162084 OICco Acquisition I, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission file number: 333-162084 OICco Acquisition I, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 27-0625383 (State or Other Jurisdictio

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K CURRENT REPORT

FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION

EX-2.1 2 f10qa063013ex2z1.htm EXHIBIT 2.1 SHARE EXCHANGE AGREEMENT SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION This SHARE EXCHANGE AGREEMENT AND PLAN OF REORGANIZATION (this “Agreement”) is entered into as of this 29th day of May, 2013 by and among, OICco Acquisition I, Inc., a Delaware corporation (“OICco”), Champion Pain Care Corp., a Nevada corporation (“CHAMPION”) and each of the share

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 . TRANSITION REPORT PURSUANT TO SECTIO

10-Q 1 f10q06301310q.htm FORM 10-Q QUARTERLY REPORT JUNE 30 2013 U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2012 . TRANSITION REPORT PURSUANT TO S

10-Q 1 f10q09301210q.htm FORM 10-Q QUARTERLY REPORT SEPTEMBER 30 2012 U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2012 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition pe

U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 . TRANSITION REPORT PURSUANT TO SECTI

10-Q 1 f10q03311310q.htm FORM 10-Q QUARTERLY REPORT MARCH 31 2013 U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission file number: 333-16208

10-K 1 f10k12311210k.htm FORM 10-K ANNUAL REPORT DECEMBER 31 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission file number: 333-162084 OICco Acquisition I, Inc. (Exact Name of Registrant as Specified in its Charter) D

-

SEC Response OICco Acquisition I, Inc. 4412 8th ST. SW . Vero Beach, FL 32968 . Phone:(772) 584-3308 June 4, 2013 Division of Corporation Finance U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549 www.sec.gov Re: OICco Acquisition I, Inc Item 4.01 Form 8K Dated May 24, 2013 File No.001-35415 Dear, Mr. Hult, We have reviewed the comment letter provided by your office and

EX-16.1

Exhibit 16.1 Auditor's Letter Exhibit 16.1

Changes in Registrant's Certifying Accountant - CURRENT REPORT ON FORM 8-K/A

Current Report on Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): 05/24/2013 OICco Acquisition I, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 333-162084 Delaware 27-0625383 (State or other jurisdiction (IRS Em

- DECEMBER 31, 2012 10-K EXTENSION

December 31, 2012 10-K Extension UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

- SEPTEMBER 30, 2012 10-Q EXTENSION

September 30, 2012 10-Q Extension UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - REPORT 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): Nov. 15, 2012 OICco Acquisition I, Inc. (Exact name of registrant as specified in its charter) Delaware 333-162084 27-0625383 (State or other jurisdiction (Commission (IRS Employer of

We consent to the inclusion in the Registration Statement (Post Effective Amendment No.8 to Form S-1) of OICco Acquisition I, Inc. of our report dated July 5, 2012, with respect to its balance sheets as of December 31, 2011 and 2010, and the related

Exhibit 23.1a We consent to the inclusion in the Registration Statement (Post Effective Amendment No.8 to Form S-1) of OICco Acquisition I, Inc. of our report dated July 5, 2012, with respect to its balance sheets as of December 31, 2011 and 2010, and the related statements of operations, stockholders' equity (deficit), and cash flows for the years then ended, and for the period from inception on

- POS AM6

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 8 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OICco Acquisition I, Inc. (Exact Name of registrant in its charter) Delaware 27-0625383 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifica

We consent to the inclusion in the registration statement (Form S-1/A7) of Imperial Automotive Group, Inc. of our report dated October 1, 2012, with respect to the balance sheet as of December 31, 2011, and the related statements of operations, stock

Exhibit 23.1b We consent to the inclusion in the registration statement (Form S-1/A7) of Imperial Automotive Group, Inc. of our report dated October 1, 2012, with respect to the balance sheet as of December 31, 2011, and the related statements of operations, stockholders’ (deficit) equity, and cash flows for the period from inception on October 12, 2011 to December 31, 2011 to be included in this

We consent to the inclusion in the Registration Statement (Post Effective Amendment No.7 to Form S-1) of OICco Acquisition I, Inc. of our reports dated July 5, 2012 for its balance sheets as of December 31, 2011 and December 31, 2010, and the related

Exhibit 23.1a We consent to the inclusion in the Registration Statement (Post Effective Amendment No.7 to Form S-1) of OICco Acquisition I, Inc. of our reports dated July 5, 2012 for its balance sheets as of December 31, 2011 and December 31, 2010, and the related statements of operations, stockholders' equity (deficit), and cash flows for the years ended, and for the period from inception on July

- POS AM6

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 7 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OICco Acquisition I, Inc. (Exact Name of registrant in its charter) Delaware 27-0625383 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifica

-

October 10, 2012 Jay Mumford Amanda Ravitz Assistant Director United States Securities and Exchange Commission Washington, D.

-

CORRESP 1 filename1.htm October 2, 2012 Brian Cascio Accounting Branch Chief Julie Sherman Staff Accountant United States Securities and Exchange Commission Washington, D.C. 20459 Re: OICco Acquisition I, Inc. Form 10-K for the Fiscal Year Ended December 31, 2011 Filed July 9, 2012 File No. 001-35415 Dear Mr. Cascio, Please find attached the Registrants response to your oral comment of Sept. 25, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A2 ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Commission file number: 333-16

10-K/A 1 oic110ka21231119282012.htm AMENDMENT NO. 2 TO ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A2 ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Commission file number: 333-162084 OICco Acquisition I, Inc. (Exact Name of Registrant as Specified in its Char

October 2, 2012

October 2, 2012 Brian Cascio Accounting Branch Chief Julie Sherman Staff Accountant United States Securities and Exchange Commission Washington, D.

-

August 21, 2012 Jay Mumford Amanda Ravitz Assistant Director United States Securities and Exchange Commission Washington, D.

-

September 13, 2012 Brian Cascio Accounting Branch Chief Julie Sherman Staff Accountant United States Securities and Exchange Commission Washington, D.

- POS AM6

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 6 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OICco Acquisition I, Inc. (Exact Name of registrant in its charter) Delaware 27-0625383 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifica

We consent to the inclusion in the Registration Statement (Post Effective Amendment No.5 to Form S-1) of OICco Acquisition I, Inc. of our reports dated July 5, 2012 for its balance sheets as of December 31, 2011 and December 31, 2010, and the related

Exhibit 23.1b We consent to the inclusion in the Registration Statement (Post Effective Amendment No.5 to Form S-1) of OICco Acquisition I, Inc. of our reports dated July 5, 2012 for its balance sheets as of December 31, 2011 and December 31, 2010, and the related statements of operations, stockholders' equity (deficit), and cash flows for the years ended, and for the period from inception on July

We consent to the inclusion in the Registration Statement (Post Effective Amendment No.6 to Form S-1) of OICco Acquisition I, Inc. of our reports for its subsidiary, Imperial Automotive Group, Inc., dated November 2, 2011, with respect to its balance

Exhibit 23.1a We consent to the inclusion in the Registration Statement (Post Effective Amendment No.6 to Form S-1) of OICco Acquisition I, Inc. of our reports for its subsidiary, Imperial Automotive Group, Inc., dated November 2, 2011, with respect to its balance sheet as of October 15, 2011, and the related statements of operations, stockholders' equity (deficit), and cash flows for the period f

We consent to the inclusion in the Registration Statement (Post Effective Amendment No.5 to Form S-1) of OICco Acquisition I, Inc. of our reports for its subsidiary, Imperial Automotive Group, Inc., dated November 2, 2011, with respect to its balance

Exhibit 23.1a Letter of Consent Exhibit 23.1a We consent to the inclusion in the Registration Statement (Post Effective Amendment No.5 to Form S-1) of OICco Acquisition I, Inc. of our reports for its subsidiary, Imperial Automotive Group, Inc., dated November 2, 2011, with respect to its balance sheet as of October 15, 2011, and the related statements of operations, stockholders' equity (deficit),

- FORM S-1 POST EFFECTIVE AMENDMENT 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OICco Acquisition I, Inc. (Exact Name of registrant in its charter) Delaware 27-0625383 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifica

We consent to the inclusion in the Registration Statement (Post Effective Amendment to Form S-1) of OICco Acquisition I, Inc. of our reports for its subsidiary, Liberty Electric Cars Limited, dated September 30, 2011, with respect to its balance shee

Exhibit 23.1b Letter of Consent Exhibit 23.1b We consent to the inclusion in the Registration Statement (Post Effective Amendment to Form S-1) of OICco Acquisition I, Inc. of our reports for its subsidiary, Liberty Electric Cars Limited, dated September 30, 2011, with respect to its balance sheets as of December 31, 2010 and 2009, and the related statements of operations, stockholders' equity (def

We consent to the inclusion in the Registration Statement (Post Effective Amendment No.5 to Form S-1) of OICco Acquisition I, Inc. of our reports for its consolidated balance sheet as of December 31, 2011, and the related consolidated statements of o

Exhibit 23.1c Letter of Consent Exhibit 23.1c We consent to the inclusion in the Registration Statement (Post Effective Amendment No.5 to Form S-1) of OICco Acquisition I, Inc. of our reports for its consolidated balance sheet as of December 31, 2011, and the related consolidated statements of operations, stockholders' equity (deficit), and cash flows for the year ended, and for the period from in

Entry into a Material Definitive Agreement - FORM 8-K CURRENT REPORT

FORM 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Exhibit 99f

Exhibit 99f Lease Exhibit 99f

EXCHANGE AGREEMENT

Exhibit 99i Exchange Agreement Exhibit 99i EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (the “Agreement”) made this 14th day of October, 2011 by and among, OICco Acquisition I, Inc.

Exhibit 99c

EX-99.1 2 posam4ex99z1.htm EXHIBIT 99C INVESTMENT AGREEMENT Exhibit 99c

Exhibit 99h

Exhibit 99h Services Agreement Exhibit 99h

Exhibit 99d

Exhibit 99d Collaboration Agreement Exhibit 99d

Exhibit 99g

Exhibit 99g Cooperation Agreement Exhibit 99g

EXCHANGE AGREEMENT

Exhibit 99j Exchange Agreement Exhibit 99j EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (the “Agreement”) made this 6th day of September 2011 by and among, OICco Acquisition I, Inc.

ADDENDUM TO EXCHANGE AGREEMENT

Exhibit 99k Addendum to Exchange Agreement Exhibit 99k ADDENDUM TO EXCHANGE AGREEMENT This ADDENDUM dated September 7, 2011, to EXCHANGE AGREEMENT dated September 6, 2011 (the “Agreement”) by and among OICco Acquisition I Inc.

- POST EFFECTIVE AMENDMENT

POST EFFECTIVE AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

-

SEC Response Letter March 27, 2012 Jay Mumford Amanda Ravitz Assistant Director United States Securities and Exchange Commission Washington, D.

1 CLAUSE PAGE NO A DEFINITIONS 1 B INTERPRETATION 1 1 OPERATIVE PART 2 2 LESSEE'S COVENANTS 2 2.1 TO PAY RENT 2 2.2 VALUE ADDED TAX 3 2.3 TO PAY OUTGOINGS 3 2.4 ELECTRICITY GAS AND OTHER SERVICES CONSUMED 3 2.5 SERVICE CHARGE 3 2.6 MANAGEMENT CHARGE

Exhibit 99e Lease 1 INDEX CLAUSE PAGE NO A DEFINITIONS 1 B INTERPRETATION 1 1 OPERATIVE PART 2 2 LESSEE'S COVENANTS 2 2.

-

SEC Response Letter February 9, 2012 Jay Mumford Allicia Lamb United States Securities and Exchange Commission Washington, D.

- POST EFFECTIVE AMENDMENT

POST EFFECTIVE AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

- FORM 8-A

FORM 8-A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OICco Acquisition I, Inc. (Exact name of registrant as specified in its charter) Delaware 27-0625383 (State of Incorporation or organization) (I.R.S. Employer Identification No.) 4412 8th

- POST EFFECTIVE AMENDMENT

POST EFFECTIVE AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Exhibit 99.c

Exhibit 99.c Exhibit 99.c 2 3 4

-

SEC Response Letter January , 2012 Russell Mancuso, Branch Chief United States Securities and Exchange Commission 100 F.

- SCHEDULE 14C INFORMATION STATEMENT

DEF 14C 1 infostatementdef14c.htm SCHEDULE 14C INFORMATION STATEMENT SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934, as amended Check the appropriate box: . Preliminary Information Statement . Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d) (2)) X . Definitive Information Statement OICCO ACQUISITION I, INC. (Name of R